Skip to main content
OpenTrials

Clinical trial condition

Stomach Diseases

Explore clinical trials studying Stomach Diseases. Study availability and eligibility vary by location and protocol.

2,578 public trials 586 recruiting studies
Refine in advanced search Browse all conditions

Stomach Diseases trial results

Active, Not Recruiting

A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.

NCT06116136

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +7 more
Locations
  • Ocala Oncology Center Pl Ocala, Florida, United States
  • Investigative Clinical Research of Indiana, Llc Noblesville, Indiana, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • The Queen Elizabeth Hospital Woodville South, Australia
View all 49 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

NCT06256328

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
  • Matsuyama Red Cross Hospital Matsuyama, Ehime, Japan
  • NHO Shikoku Cancer Center Matsuyama, Ehime, Japan
View all 63 locations
View Trial Details
Active, Not Recruiting

Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer

NCT07448493

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +17 more
Locations
  • Gomel Regional Clinical Oncology Dispensary (OKOD) Homyel, Belarus
  • Kaliningrad Regional Clinical Oncology Center Kaliningrad, Russia
  • Moscow Regional Oncology Hospital No. 62 Krasnogorsk, Russia
  • A.S. Loginov Moscow Clinical Scientific Center Moscow, Russia
View all 15 locations
View Trial Details
Active, Not Recruiting

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

NCT05438420

Conditions
Cervical Cancer, Digestive System Diseases, Digestive System Neoplasms, +25 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • CHA Bundang Medical Center Seongnam-si, South Korea
  • Asan Medical Center Seoul, South Korea
View Trial Details

Related conditions